A cytological evaluation of combined therapy in the 6C3HED lymphosarcoma. I. -SH-containing analogs in combination with nitrogen mustard and mapharsen.
D000970:Antineoplastic Agents / Q000494:pharmacology*; D001152:Arsenicals / Q000494:pharmacology*; D006801:Humans; D008223:Lymphoma; D008228:Lymphoma, Non-Hodgkin; D008466:Mechlorethamine; D009930:Organic Chemicals; D013438:Sulfhydryl Compounds / Q000494:pharmacology*
D000970:Antineoplastic Agents; D001152:Arsenicals; D009930:Organic Chemicals; D013438:Sulfhydryl Compounds; D008466:Mechlorethamine; C100059:oxophenarsine
ANTINEOPLASTIC AGENTS/pharmacology; LYMPHOSARCOMA/experimental; OXOPHENARSINE/pharmacology; SULFHYDRYL COMPOUNDS/pharmacology